PARR Sensitivity for B-Cell is 90.71% and for T-Cell is 85.45%.
Current therapy will not affect our AI predictions or immunoprofile results. However, reduction of tumor size caused by therapy may increase the likelihood of service failure due to insufficient cells. In the event of service failure, you will not be billed.
We will send you another batch of media tubes you could use. Please make the supply request on the Vet Portal > Request Supplies page.
Yes, probably the patient would be taking some form of drug treatment when we look at the progression-free survival graph. Basically, the patients were not treatment free at the time.
Yes, all account users can be associated with multiple hospitals. Please email support@imprimedicine.com if you want to add hospitals or clinics to your account.
If the patient is suspected of leukemia, blood collected in the EDTA tube should be fine. If it is lymphoma, we might need FNA from the affected organ/lymph node. We can suggest FNA in ImpriMed media tube (1) and 2ml of blood sample in an EDTA tube.
